belantamab mafodotin (TECVAYLI) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA First in Class Breakthrough Therapy FDA Accelerated Approval FDA
Back

Drug Pricing Summary

VA Big4

$6164.4200

VA FSS

$8152.2200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
belantamab mafodotin 50 mg / 1 mL (1 mL INJECTION) $6164.4200 VA Big4
  • Blenrep (1)
    		•  GlaxoSmithKline
    belantamab mafodotin 50 mg / 1 mL (1 mL INJECTION) $8152.2200 VA FSS
  • Blenrep (1)
    		•  GlaxoSmithKline

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue